Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-054899

Director sold 41,666 shares at an average $177.50 ($7,395,887)

  • Director acquired 41,666 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hindson Benjamin J. · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Exercise or conversion : show line 1 in the form +41,666 $5.04 $209,997 88,783 D
2021-09-01 Sale : show line 2 in the form −1,049 $174.39 $182,935 87,734 D
2021-09-01 Sale : show line 3 in the form −2,728 $175.69 $479,292 85,006 D
2021-09-01 Sale : show line 4 in the form −7,530 $176.65 $1,330,156 77,476 D
2021-09-01 Sale : show line 5 in the form −21,145 $177.72 $3,757,830 56,331 D
2021-09-01 Sale : show line 6 in the form −8,586 $178.56 $1,533,138 47,745 D
2021-09-01 Sale : show line 7 in the form −628 $179.20 $112,536 47,117 D
Open-market sales · 41,666 sh · avg $177.50 · $7,395,887

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-09-01 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −41,666 $5.04 2028-11-02 41,666 102,782 D
Loading xslF345X03/doc4.xml…